Navigate this market better. Subscribe for FREE stock alerts and information.

Thursday, July 7, 2011

Medtronic deals to expand surgical device offerings, (NYSE: MDT), (NYSE: COV), (NYSE: JNJ)

Medtronic Inc (MDT.N) on Thursday said it struck deals to acquire two privately held companies in a bid to expand its presence in advanced surgical devices dominated by rivals Covidien Plc (COV.N) and Johnson & Johnson (JNJ.N). Medtronic, the world's largest stand alone medical device company, agreed to purchase the part of Salient Surgical Technologies Inc that it does not already own, for about $480 million. Including Medtronic's existing ownership stake in the manufacturer of instruments used for haemostatic sealing of soft tissue and bone, the value of the transaction is $525 million. Salient has annualized revenue of about $100 million.

Medtronic, Inc. (Medtronic), incorporated in 1957, is a medical technology company. Shares of MDT traded higher by 0.35% or $0.135/share to $38.22. In the past year, the shares have traded as low as $30.80 and as high as $43.33. On average, 6009550 shares of MDT exchange hands on a given day and today's volume is recorded at 5218424.

Covidien plc: NYSE:COV quotes & news - Google Finance Source